Latest news
Scholar Rock Overcomes Manufacturing Hurdle to Keep Lead Drug FDA Review on Schedule - BenzingaBenzinga · Mon, 10 Aug 2026 16:03:50 GMTNovo’s Catalent plant ditched in FDA refiling of SMA drug - Fierce PharmaFierce Pharma · Mon, 10 Aug 2026 14:06:15 GMTScholar Rock Reports Second Quarter 2026 Financial Results and Recent Business Highlights - BioSpaceBioSpace · Thu, 06 Aug 2026 12:39:18 GMT